US Patent Issued to Repare Therapeutics on June 23 for "Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors" (Canadian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,481, issued on June 23, was assigned to Repare Therapeutics Inc. (St-Laurent, Canada).

"Substituted 2-morpholinopyridine derivatives as ATR kinase inhibitors" was invented by Sheldon N. Crane (Notre Dame de I'lle Perrot, Canada), Vouy-linh Truong (Pierrefonds, Canada), Abbas Abdoli (Montreal), Jean-Francois Truchon (Saint-Laurent, Canada), Cameron Black (Baie-D'Urfe, Canada), Stephane Dorich (Point-Claire, Canada), Lee Fader (Hawkesbury, Canada), Stephanie Lanoix (Mansfield, Canada), Paul Jones (Verdun, Canada), Miguel St-Onge (Vaudreuil-Dorion, Canada), Audrey Picard (Mirabel, Canada) and Cyrus M. Lacbay (Montreal).

According to the abstract* released by the U.S. Patent & Tradem...